Center for Financial Planning’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Center for Financial Planning’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-128	Closed	-$28K	–	560
2021 Q1	$28K	Sell	128 -55	-30%	-$10.3K	0.01%	271
2020 Q4	$21K	Hold	183	–	–	0.01%	283
2020 Q3	$18K	Hold	183	–	–	0.01%	273
2020 Q2	$22K	Sell	183 -9	-5%	-$1.02K	0.01%	252
2020 Q1	$17K	Hold	192	–	–	0.01%	272
2019 Q4	$20K	Buy	+192	New	+$21.5K	0.01%	265

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Center for Financial Planning's GWPH Position: Q2 2021 in Review

Center for Financial Planning sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 128 shares — an estimated $28K sold.

Center for Financial Planning first reported a position in GWPH in Q4 2019 and held it in 6 quarters. The position peaked at $28K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Center for Financial Planning reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Center for Financial Planning sold 128 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $28K.
Center for Financial Planning first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 6 quarters.
Center for Financial Planning's GW Pharmaceuticals Plc American Depositary Shares position peaked at $28K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Center for Financial Planning's 13F filing for Q2 2021, filed 29 Jul 2021.